Articles tagged with Clinical Research
Researchers found that acoustic stimulation improved postconcussive symptoms in individuals with mild traumatic brain injury, although the benefits were largely sustained. The study's results suggest that listening to acoustic stimulation based on brain electrical activity may not improve symptoms more than randomly generated sound sti...
A recent study analyzed asthma mortality rates in China and the US from 1990 to 2019, revealing substantial differences in mortality rates and risk factors. The study found that smoking was a leading risk factor for asthma mortality in China, while high body mass index (BMI) was a larger public health challenge in the US.
Thirty-two institutions earned the SET-10 distinction, with top ten recognized globally for their dedication to advancing scientific knowledge in interventional cardiovascular medicine. The rankings span six categories and acknowledge excellence within and outside the United States.
A phase 2 trial found that durvalumab is safe and may benefit overall survival in non-small cell lung cancer patients with borderline performance status. The study also showed stable quality of life and a lower incidence of severe treatment-related adverse events compared to platinum doublet chemotherapy.
Researchers analyzed genes and brain tissue of patients with Alzheimer's disease to find sex-specific differences in immune function, cellular metabolism, and communication between brain cells. The study suggests that these differences contribute to women's increased risk for the disease and its severity.
A new study by the University of Plymouth reveals that chlorine disinfectants used in hospitals are no more effective at killing off hospital superbugs than water. The research highlights the need for alternative strategies to tackle Clostridioides difficile, which causes diarrhoea, colitis and other bowel complications globally.
Testing wastewater for COVID-19 provides a more accurate forecast of new hospital admissions than clinical data. The researchers found that wastewater surveillance improved prediction models by 11 and 15 percent over models using case data and regional estimates, respectively.
A new AI program created by researchers at UF and NVIDIA can generate medical records so well that human physicians couldn't tell the difference. The GatorTronGPT model uses a large language model to mimic natural human language, overcoming hurdles such as protecting patients' privacy and being highly technical.
A systematic review found that only 203 images of 60 patients were included in 152 studies on psoriasis treatment outcomes over 20 years. The low image sharing rate complicates patient understanding and highlights the need for more clinical images.
A comprehensive meta-analysis led by Dr. Micheal Sandbank reveals that many low-quality studies are driving intervention recommendations and patient outcomes in early childhood autism care. The study highlights the need for more rigorous research to understand the positive and negative effects of various interventions.
A groundbreaking study published in JAMA found that excluding aspirin from the antithrombotic regimen for patients with a fully magnetically levitated left ventricular assist device (LVAD) resulted in a significant decrease in major nonsurgical bleeding events. This approach is safe and beneficial, challenging conventional practice and...
Researchers found that three medicines - CGRP inhibitors, amitriptyline, and simvastatin - had a better preventive effect on migraine than traditional beta blockers. This discovery could have significant implications for healthcare costs, as the cheaper alternatives may offer similar treatment effects.
Rahn Baily, MD, has made significant contributions to the field of psychiatry and healthcare reform through his research on health disparities, violence, and mental illness. He will receive the prestigious Solomon Carter Fuller Award for his outstanding achievements in addressing pressing societal needs.
The American Gastroenterological Association released a new guideline recommending the use of biomarkers to help manage Crohn’s disease. Biomarkers such as C-reactive protein and fecal calprotectin can measure levels of inflammation, helping doctors assess disease activity and guide treatment decisions.
A new study has uncovered the molecular causes of a rare developmental brain condition in children, known as Autosomal Recessive ACBD6-related disorder. The research team identified defects in the acyl-CoA-binding domain-containing protein 6 (ACBD6) gene as the underlying cause, leading to delays in cognitive and motor skills development.
A study by Chung Ang University researchers found that heart and multi-organ failures were the most common causes of death among critically ill patients receiving ECMO. The study identified key risk factors, including ECMO weaning failure, new-onset renal failure, and low average mean arterial pressure, to minimize mortality rates.
Multimodal neuromonitoring (MNM) tracks blood flow, pressure, oxygen and glucose levels in the brain to inform treatment decisions. MNM has improved clinical outcomes for patients with severe traumatic brain injuries at the University of Cincinnati.
Researchers developed an AI model using epigenetic factors to predict patient outcomes across multiple cancer types. The model successfully divided patients into two groups with different survival chances, and its genes were found to have a significant overlap with cluster-defining signature genes.
Researchers Reshmi Parameswaran and Carlos Subauste at Case Western Reserve University have received funding for their work on finding new treatments for B-cell cancer and diabetic retinopathy, a leading cause of blindness. They aim to develop more effective cell therapies and inhibitors to treat these diseases.
The November issue of CHEST journal features cutting-edge research on asthma, COPD, diffuse lung disease, and thoracic oncology. A new guideline provides updated recommendations for patients with stable COPD, while home spirometry is shown to be less consistent than clinic spirometry in monitoring lung function in patients with asthma.
Two phase-3 clinical trials demonstrate a significant increase in overall survival and progression-free survival for bladder cancer patients treated with immunotherapy combinations. The studies show a 22% reduction in the risk of death compared to chemotherapy alone, providing a promising new approach for treating advanced bladder cancer.
Researchers at Weill Cornell Medicine found that partnering with local religious leaders increased the adoption of family planning methods in Tanzania. The approach, which involves workshops and training for faith leaders, led to a 19% rise in contraceptive uptake in communities where religious leaders participated.
Researchers found a modest improvement in predicting pathologic response to chemotherapy using molecular subtypes, but no association with overall survival and progression-free survival. The study suggests the need for subtype-directed therapy trials to test targeted treatments.
A new Kaiser Permanente peer support program helped reduce physician burnout and improve well-being, leading to a positive impact on hospital culture. The program, which allows for third-party referrals, has been shown to increase the likelihood of physicians recommending it to others.
Researchers developed 'tension-activated repair patches' that release anti-inflammatory molecules, helping discs regain tension and reverse herniation. The patch uses natural biomechanical movement to activate its release, offering a potential early intervention for preventing worsening pain related to disc degeneration.
Researchers characterized changes in cognitive behaviors, neuronal morphology and gene expression in a tauopathy mouse model. The study found significant decreases in dendritic arborization and synaptic gene upregulation over time.
Researchers tested EMDR, a therapy proven to treat PTSD and depression, to reduce addiction cravings. The study found Addiction-focused EMDR was as effective as cognitive behavioral therapy for cravings, reducing symptoms by clinically significant amounts.
A comprehensive review study identifies emerging biomarkers that mirror efforts to halt beta-cell autoimmunity, offering potential applications in clinical practice. The study's findings may improve the management of type 1 diabetes during its partial remission phase.
Researchers discovered COVID-19 causes epigenetic scars in lung tissue that lead to hyperinflammation and fibrosis. These changes are associated with increased interferons and chemokines, promoting inflammation.
A new study by Harvard researchers proposes that social factors, such as gendered variables, may better explain observed sex disparities in adverse drug events. The study highlights the need to consider social and structural differences in individuals' experiences and health outcomes.
Researchers have summarized recent advances in enzyme-activated near-infrared fluorescent probes for non-invasive visualization of enzyme dynamics and disease status. These probes offer high specificity, sensitivity, and biocompatibility, making them valuable assets in biomedical research and healthcare.
University of Kentucky researcher Kenneth S. Campbell has helped map out an important part of the heart on a molecular level, solving a 60-year-old mystery about the human cardiac myosin filament. The study reveals three different types of crowns and provides new information about how molecules interact in the heart.
A study published in The Lancet Neurology found that monitoring brain injury biomarkers and glucose variation over the first week of hospitalization can provide a more accurate picture of the pathological process. This allows for division into different groups with distinct disease trajectories and prognoses, enabling personalized trea...
Jenny Wilkerson receives $1.94 million grant to develop novel models and investigate antinociceptive profiles of basal sex hormone alterations in patients with chronic post-op pain. The study aims to answer questions about the impact of altered sex hormone levels on recovery times, drug effectiveness, and long-term health.
Researchers found that a molecule associated with the X chromosome contributes to lupus development in females. The X-inactive specific transcript (XIST) triggers an immune response that damages healthy tissue, leading to muscle and joint pain, skin rashes, and other complications.
Researchers from Mass General Brigham found that patients experiencing virologic rebound after treatment may remain contagious. The study suggests that individuals shed live virus when experiencing a rebound, implying the potential for transmission after initially recovering from the virus.
A three-year intensive treatment strategy to lower systolic blood pressure below 120mmHg significantly reduced cardiovascular events, including heart attack, stroke, and death, compared to standard treatment. The study found that participants in the intensive group experienced fewer major vascular events and deaths over a two-year period.
A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.
A new strategy that trains healthcare providers to deliver team-based care has been found to significantly lower blood pressure in low-income patients compared to usual care methods. Patients treated by the multi-faceted approach saw a mean systolic blood pressure drop of 16 mmHg, while those in the usual care group saw a 9 mmHg drop.
A recent study found that most cannabis users (80%) have stopped using over-the-counter or prescription sleep aids and instead prefer inhaling high-THC cannabis to help with falling asleep. The study also showed that cannabis users experienced fewer headaches, nausea, and dry mouth compared to traditional sleep aids.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
Lepodisiran, a short interfering RNA, targets hepatic synthesis of apolipoprotein(a), reducing serum lipoprotein(a) concentrations. Phase 1 study results support further investigation of lepodisiran's efficacy in treating elevated lipoprotein(a) levels.
A new study suggests that a PCSK9 inhibitor given every 1-3 months may effectively lower bad cholesterol levels in people with non-genetic hypercholesterolemia. The medication, recaticimab, showed similar effectiveness and safety as other PCSK9 inhibitors when administered less frequently.
A randomized controlled trial suggests that a more liberal approach to red blood cell transfusions for heart attack patients with anemia may benefit outcomes without significant risk. The study found no statistically significant difference between two transfusion strategies, but results suggest a possible benefit of liberal transfusions.
A global study found that apixaban reduced the risk of stroke and blood clotting by 37% in patients with device-detected atrial fibrillation, also known as sub-clinical atrial fibrillation (SCAF). The medication also reduced fatal or disabling stroke by 49%.
A single dose of zilebesiran safely and effectively lowered systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months. The study found significant reductions in daytime and nighttime systolic blood pressure, as well as low rates of adverse events.
A study found that pregnant women with high blood pressure who received tight blood pressure control immediately after pregnancy had lower blood pressure levels and improved cardiac function compared to those with usual care. This could lead to a reduced risk of cardiovascular disease, including heart attacks and strokes.
A phase 4 clinical trial found that apixaban, an anti-clotting medication, reduced the rate of stroke and blood clots in adults with implanted heart devices experiencing short bouts of asymptomatic, irregular heart rhythms. The study suggests that these individuals may benefit from receiving an anticoagulant.
A single infusion of CRISPR-based gene-editing therapy significantly reduced LDL cholesterol levels in people with heterozygous familial hypercholesterolemia, a condition that increases heart attack risk. The treatment has shown potential as a long-term or permanent option for high LDL-C control.
The ORBITA-2 trial found that stenting improves symptoms compared to a placebo procedure, providing evidence-based treatment for stable chest pain. The study suggests updating guidelines for stable coronary artery disease and offers patients and medical teams two treatment strategies with similar benefits.
A four-year blood-pressure intervention significantly reduced the risk of developing dementia among adults with high blood pressure, compared to those who received usual care. The study found that lowering systolic blood pressure to less than 130 mm Hg and diastolic blood pressure to less than 80 mm Hg reduced dementia risk.
A new study shows that autologous stem cell transplant can improve nearly all measures for two years following treatment in patients with refractory juvenile systemic sclerosis. The procedure significantly reduces disease severity and improves skin thickness, intestinal symptoms, and lung function, offering a life-saving intervention f...
A recent study published in Circulation found that non-ischemic or dual cardiomyopathy occurs in 1 out of every 6 patients with coronary artery disease. These conditions are characterized by heart muscle damage and can lead to worse long-term outcomes. The researchers used cardiac MRI to determine the cause of cardiomyopathy, which has...
Treatment with obinutuzumab has been shown to preserve kidney function and prevent flares in patients with lupus nephritis. The addition of obinutuzumab to standard treatment reduced the risk of composite outcomes, such as death or treatment failure, by 60%.
A new risk calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney, and metabolic health. The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex, without including race as a factor.
Researchers successfully produced alstonine, a naturally occurring substance with potential for treating mental disorders, using genetically engineered yeast cells. The yeast platform has the potential to discover and develop plant-based medicines, including those for schizophrenia.
A clinical trial found that high levels of anti-Ro/SSA antibodies in pregnant women are associated with an increased risk of fetal atrioventricular block (AVB), a condition that can be fatal. Home-based fetal heart rate monitoring reliably detects conduction abnormalities, potentially reducing the need for serial echocardiograms.
Researchers found that stopping TNF inhibitors led to more flares and lower remission rates among RA patients who were already in sustained remission. This contrasts with those who continued treatment, highlighting the importance of personalized treatment approaches for RA patients.
A multicenter study identifies genetic and immune-related changes that impact treatment responses in newly diagnosed multiple myeloma patients. The researchers found a complex interplay between tumor genomic features and immune microenvironment changes drives stronger treatment responses and prolonged progression-free survival.
A survey found that 42% of primary care physicians are unaware of biologic treatments for asthma, and 82% do not get necessary labs to determine treatment options. This lack of knowledge can lead to delayed referrals to asthma specialists and reduced effectiveness in managing symptoms.